NO20013146L - Means for the treatment of visual cell dysfunction - Google Patents
Means for the treatment of visual cell dysfunctionInfo
- Publication number
- NO20013146L NO20013146L NO20013146A NO20013146A NO20013146L NO 20013146 L NO20013146 L NO 20013146L NO 20013146 A NO20013146 A NO 20013146A NO 20013146 A NO20013146 A NO 20013146A NO 20013146 L NO20013146 L NO 20013146L
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- cell dysfunction
- visual cell
- visual
- dysfunction
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11393998P | 1998-12-24 | 1998-12-24 | |
| PCT/JP1999/007161 WO2000038703A1 (en) | 1998-12-24 | 1999-12-20 | Agent for treating visual cell function disorder |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20013146D0 NO20013146D0 (en) | 2001-06-22 |
| NO20013146L true NO20013146L (en) | 2001-08-20 |
Family
ID=22352417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20013146A NO20013146L (en) | 1998-12-24 | 2001-06-22 | Means for the treatment of visual cell dysfunction |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1140134A1 (en) |
| JP (1) | JP2002542150A (en) |
| KR (1) | KR20010099928A (en) |
| CN (1) | CN1224420C (en) |
| AR (1) | AR022017A1 (en) |
| AU (1) | AU781049B2 (en) |
| BR (1) | BR9917113A (en) |
| CA (1) | CA2356382A1 (en) |
| MX (1) | MXPA01006449A (en) |
| NO (1) | NO20013146L (en) |
| NZ (1) | NZ513111A (en) |
| TW (1) | TW546145B (en) |
| WO (1) | WO2000038703A1 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070032853A1 (en) | 2002-03-27 | 2007-02-08 | Hossainy Syed F | 40-O-(2-hydroxy)ethyl-rapamycin coated stent |
| AU2003209297A1 (en) | 2002-01-18 | 2003-09-02 | Massachusetts Eye And Ear Infirmary | Methods and compositions for preserving the viability of photoreceptor cells |
| JP2006511475A (en) | 2002-09-18 | 2006-04-06 | トラスティーズ オブ ザ ユニバーシティ オブ ペンシルベニア | Method for suppressing choroidal neovascular disease |
| US20050118344A1 (en) | 2003-12-01 | 2005-06-02 | Pacetti Stephen D. | Temperature controlled crimping |
| SI1848431T1 (en) | 2005-02-09 | 2016-05-31 | Santen Pharmaceutical Co., Ltd. | Liquid formulations for treatment of diseases or conditions |
| US7592330B2 (en) | 2005-08-08 | 2009-09-22 | Massachusetts Eye And Ear Infirmary | Methods and compositions for preserving the viability of photoreceptor cells |
| JP5528708B2 (en) | 2006-02-09 | 2014-06-25 | 参天製薬株式会社 | Stable formulations and methods for preparing and using them |
| US8222271B2 (en) | 2006-03-23 | 2012-07-17 | Santen Pharmaceutical Co., Ltd. | Formulations and methods for vascular permeability-related diseases or conditions |
| JP7431451B2 (en) | 2018-10-15 | 2024-02-15 | 国立大学法人大阪大学 | Pharmaceuticals for improving or preventing symptoms related to the retina and/or photoreception, and methods for screening for substances that improve or preventing symptoms related to the retina and/or photoreception |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69124380T2 (en) * | 1990-08-23 | 1997-08-14 | Univ New York | METHOD AND COMPOSITIONS FOR THE TREATMENT BY T-CELL-MEDIATED DISEASES |
| ZA924953B (en) * | 1991-07-25 | 1993-04-28 | Univ Louisville Res Found | Method of treating ocular inflammation |
| US5922773A (en) * | 1992-12-04 | 1999-07-13 | The Children's Medical Center Corp. | Glaucoma treatment |
| US5597809A (en) * | 1994-06-23 | 1997-01-28 | Massachusetts Eye & Ear Infirmary | Treatment of optic neuritis |
| AU727080B2 (en) * | 1997-06-30 | 2000-11-30 | Allergan, Inc. | Calcium blockers to treat proliferative vitreoretinopathy |
| CZ287497B6 (en) * | 1997-12-30 | 2000-12-13 | Galena, A. S. | Topic eye preparations containing immunosuppressive substances |
| US6376517B1 (en) * | 1998-08-14 | 2002-04-23 | Gpi Nil Holdings, Inc. | Pipecolic acid derivatives for vision and memory disorders |
-
1999
- 1999-12-20 NZ NZ513111A patent/NZ513111A/en unknown
- 1999-12-20 BR BR9917113-9A patent/BR9917113A/en not_active IP Right Cessation
- 1999-12-20 AU AU16906/00A patent/AU781049B2/en not_active Ceased
- 1999-12-20 JP JP2000590655A patent/JP2002542150A/en active Pending
- 1999-12-20 KR KR1020017008060A patent/KR20010099928A/en not_active Application Discontinuation
- 1999-12-20 CA CA002356382A patent/CA2356382A1/en not_active Abandoned
- 1999-12-20 WO PCT/JP1999/007161 patent/WO2000038703A1/en not_active Application Discontinuation
- 1999-12-20 CN CNB998162760A patent/CN1224420C/en not_active Expired - Fee Related
- 1999-12-20 EP EP99959930A patent/EP1140134A1/en not_active Withdrawn
- 1999-12-20 MX MXPA01006449A patent/MXPA01006449A/en unknown
- 1999-12-22 TW TW088122634A patent/TW546145B/en not_active IP Right Cessation
- 1999-12-23 AR ARP990106748A patent/AR022017A1/en not_active Application Discontinuation
-
2001
- 2001-06-22 NO NO20013146A patent/NO20013146L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA01006449A (en) | 2002-04-24 |
| JP2002542150A (en) | 2002-12-10 |
| CN1224420C (en) | 2005-10-26 |
| AU1690600A (en) | 2000-07-31 |
| CN1352565A (en) | 2002-06-05 |
| BR9917113A (en) | 2001-10-23 |
| EP1140134A1 (en) | 2001-10-10 |
| KR20010099928A (en) | 2001-11-09 |
| AU781049B2 (en) | 2005-05-05 |
| AR022017A1 (en) | 2002-09-04 |
| WO2000038703A1 (en) | 2000-07-06 |
| TW546145B (en) | 2003-08-11 |
| CA2356382A1 (en) | 2000-07-06 |
| NO20013146D0 (en) | 2001-06-22 |
| NZ513111A (en) | 2003-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS2494B (en) | Use of morpholinol for the treatment of sexual dysfunction | |
| DE60020327D1 (en) | The water treatment unit | |
| NO20012160D0 (en) | Device for the treatment of macular degeneration | |
| EE200200710A (en) | Substituted bicyclic derivatives for the treatment of abnormal cell growth | |
| DE69828821D1 (en) | WATER TREATMENT PROCESS | |
| NO952749L (en) | Water treatment agent | |
| EA199900336A3 (en) | APPARATUS FOR WATER TREATMENT WITH INDICATOR OF THE DEGREE OF MEANS OF CLEANING | |
| DK0965566T3 (en) | Process for the treatment of organic wastewater | |
| NO20010456D0 (en) | Triazolopyridines for the treatment of thrombosis problems | |
| NO20013146L (en) | Means for the treatment of visual cell dysfunction | |
| NO20012106L (en) | Means for the treatment of disorders of bone metabolism | |
| NO20013596L (en) | Sludge treatment | |
| AU5509099A (en) | Pyridinones for the treatment of sexual dysfunction | |
| AU4774599A (en) | Process for the treatment of waste water | |
| DK1054868T3 (en) | Substituted pyridinoarylpiperazines suitable for the treatment of prostate hyperplasia | |
| AU3814599A (en) | Use of erythropoietin for the treatment of haemochromatoses | |
| NO20011892L (en) | 3-tetrahydropyridin-4-yl indoles for the treatment of psychotic disorders | |
| NO20003481D0 (en) | Procedure for the treatment of COPD | |
| FI982378A0 (en) | Arrangement for the study of the object | |
| NO20012612D0 (en) | Isonipecotamides for the treatment of integrin-mediated disorders | |
| NO20012616D0 (en) | Means for the treatment of erectile malfunction | |
| GB2332849B (en) | Apparatus for the treatment of soil | |
| DE50015962D1 (en) | System for the treatment of drinking water | |
| NO996166L (en) | Procedures for the treatment of odluor | |
| ZA994585B (en) | Treatment of water. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |